lapatinib has been researched along with meclofenamic acid in 2 studies
| Studies (lapatinib) | Trials (lapatinib) | Recent Studies (post-2010) (lapatinib) | Studies (meclofenamic acid) | Trials (meclofenamic acid) | Recent Studies (post-2010) (meclofenamic acid) |
|---|---|---|---|---|---|
| 1,919 | 305 | 1,442 | 1,001 | 55 | 72 |
| Protein | Taxonomy | lapatinib (IC50) | meclofenamic acid (IC50) |
|---|---|---|---|
| Prostaglandin G/H synthase 1 | Ovis aries (sheep) | 0.0675 | |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 0.2115 | |
| Mitogen-activated protein kinase 1 | Homo sapiens (human) | 3.144 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.1618 | |
| Prostaglandin G/H synthase 2 | Rattus norvegicus (Norway rat) | 0.1 | |
| Aldo-keto reductase family 1 member C3 | Homo sapiens (human) | 0.5307 | |
| Aldo-keto reductase family 1 member C2 | Homo sapiens (human) | 8.74 | |
| Aldo-keto reductase family 1 member C1 | Homo sapiens (human) | 2.3533 | |
| Prostaglandin G/H synthase 2 | Mus musculus (house mouse) | 0.164 | |
| Prostaglandin G/H synthase 1 | Rattus norvegicus (Norway rat) | 0.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for lapatinib and meclofenamic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for lapatinib and meclofenamic acid
| Article | Year |
|---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |